{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T21:33:32Z","timestamp":1776548012935,"version":"3.51.2"},"reference-count":14,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.clinthera.2004.11.002","type":"journal-article","created":{"date-parts":[[2005,1,6]],"date-time":"2005-01-06T12:15:12Z","timestamp":1105013712000},"page":"1890-1894","source":"Crossref","is-referenced-by-count":33,"title":["Retrospective evaluation of interferon-beta treatment in subacute sclerosing panencephalitis"],"prefix":"10.1016","volume":"26","author":[{"given":"Banu","family":"Anlar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer Faruk","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alev","family":"Guven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma Mujgan","family":"Sonmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulsen","family":"Kose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem","family":"Herguner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2004.11.002_bib1","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archneur.1979.00500460044004","article-title":"The variable natural history of subacute sclerosing panencephalitis: A study of 118 cases from the Middle East","volume":"36","author":"Risk","year":"1979","journal-title":"Arch Neurol."},{"key":"10.1016\/j.clinthera.2004.11.002_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/088307389801301106","article-title":"Beta-interferon plus mosiplex in the treatment of subacute sclerosing panencephalitis","volume":"13","author":"Anlar","year":"1998","journal-title":"J Child Neurol."},{"key":"10.1016\/j.clinthera.2004.11.002_bib3","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1212\/WNL.55.10.1497","article-title":"Interferon beta-lb increases interleukin-10 in a model of T cell-microglia interaction: Relevance to MS","volume":"55","author":"Chabot","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2004.11.002_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0165-5728(02)00098-X","article-title":"Interferon-beta directly influences monocyte infiltration into the central nervous system","volume":"127","author":"Floris","year":"2002","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.clinthera.2004.11.002_bib5","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/088307380101601206","article-title":"Tissue inflammatory response in subacute sclerosing panencephalitis (SSPE)","volume":"16","author":"Anlar","year":"2001","journal-title":"J Child Neurol."},{"key":"10.1016\/j.clinthera.2004.11.002_bib6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1212\/WNL.42.3.488","article-title":"Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis","volume":"42","author":"Yalaz","year":"1992","journal-title":"Neurology."},{"key":"10.1016\/j.clinthera.2004.11.002_bib7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ana.410110407","article-title":"Long-term follow-up of patients with subacute sclerosing panencephalitis treated with mosiplex","volume":"11","author":"Dyken","year":"1982","journal-title":"Ann Neurol."},{"key":"10.1016\/j.clinthera.2004.11.002_bib8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/088307389701200611","article-title":"Mental assessment in subacute sclerosing panencephalitis: Hacettepe Cognitive Short Assessment Scale","volume":"12","author":"\u00d6ktem","year":"1997","journal-title":"J Child Neurol."},{"key":"10.1016\/j.clinthera.2004.11.002_bib9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/088307380301801201","article-title":"Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): International multicenter study","volume":"18","author":"Gascon","year":"2003","journal-title":"J Child Neurol."},{"key":"10.1016\/j.clinthera.2004.11.002_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/08830738030180020701","article-title":"Combined treatment with subcutaneous interferon-alpha, oral isoprinosine, and lamivudine for subacute sclerosing panencephalitis","volume":"18","author":"Aydin","year":"2003","journal-title":"J Child Neurol."},{"key":"10.1016\/j.clinthera.2004.11.002_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.braindev.2003.11.004","article-title":"Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan","volume":"26","author":"Anlar","year":"2004","journal-title":"Brain Dev."},{"key":"10.1016\/j.clinthera.2004.11.002_bib12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/088307380401900614","article-title":"Preliminary results for treatments in subacute sclerosing panencephalitis have problems?","volume":"19","author":"Anlar","year":"2004","journal-title":"J Child Neurol."},{"key":"10.1016\/j.clinthera.2004.11.002_bib13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1212\/WNL.48.2.526","article-title":"Long-term followup of subacute sclerosing panencephalitis patients treated with intraventricular alpha-interferon","volume":"48","author":"Anlar","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2004.11.002_bib14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/135245850200800102","article-title":"Use of interferon beta in multiple sclerosis: Rationale for early treatment and evidence for dose- and frequency-dependent effects on clinical response","volume":"8","author":"Coyle","year":"2002","journal-title":"Mutt Scler"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0149291804803527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0149291804803527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T10:56:00Z","timestamp":1548845760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0149291804803527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["0149291804803527"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2004.11.002","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}